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This study aims to evaluate the 4 non- pharmacological strategies adopted by patients 
for hypertension control and patient characteristics that affect the choice of strate-
gies. Four thousand hypertensive patients aged ≥18 years were selected from the 
National Health and Nutrition Examination Survey. Odds ratios of the choice of strate-
gies were analyzed using weighted logistic models. Clinical recommendations of non- 
pharmacological strategies for hypertension control were relatively low. More exercise 
was the least frequent strategy used for hypertension control. More patients reported 
using ≥3 strategies than using ≤2 strategies (79.1% vs 20.9%, P < .0001). Non- Hispanic 
blacks were more likely to use each individual strategy and to use ≥3 strategies simul-
taneously. Patients with obesity and diabetes were less likely to attempt weight con-
trol or more exercise, but more likely to use ≥3 strategies than peers. Educational 
programs should be developed to enhance physician’s advice for lifestyle modifica-
tions and to increase patient’s acceptance of physical activity.
1  | INTRODUCTION
High blood pressure (BP) or hypertension is a chronic medical disorder 
that affects 85.7 million adults in the United States (US).1 It is a major 
risk factor for adverse cardiovascular and renal diseases.2-5 While drug 
therapies have provided the capability for lowering BP in persons with 
hypertension,6 hypertension remains a major public health concern 
and about half of hypertensive individuals do not have their BP con-
trolled below 140/90 mm Hg.7,8
Beyond antihypertensive drugs, numerous non- pharmacological 
strategies have been assessed and recommended to improve BP con-
trol.9-11 Intervention trials show that several self- managed strategies, 
including weight loss12,13; reduced sodium intake14; increased fruit, 
vegetable,15 and potassium intake16; reduced alcohol intake17; and 
moderate or vigorous physical activity13 are efficacious in lowering 
BP. These strategies play a major role in cardiovascular prevention and 
treatment through effects on BP, and have been recommended by the 
American Heart Association and endorsed by the American Society 
of Hypertension for preventing the adverse health consequences of 
hypertension.15 However, the significant efficacy of strategies does 
not necessarily translate into patients’ adoption of them for lowering 
BP. How commonly these strategies are adopted and whether one 
strategy is more frequently used than the alternative ones for self- 
management of BP have not been evaluated among hypertensive pa-
tients in the US. Knowledge of which specific strategies are frequently 
adopted, along with the factors that affect the choice of strategies 
may inform efforts to improve non- pharmacological interventions di-
rected at lowering BP.
In this study, individuals of age 18 years or over with a diagnosis of 
hypertension were selected from the US National Health and Nutrition 
Examination Survey (NHANES). Among the patients whose physicians 
had recommended non- pharmacologic strategies, the adoption rate 
of each strategy and the number of strategies adopted by hyperten-
sive patients after the recommendation were calculated. In addition, 
the characteristics associated with the number of adopted strategies 
were identified. The findings would be critical for informing physicians’ 
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recommendations regarding non- pharmacologic therapies of hyperten-
sion as an aide to drug therapy, allowing physicians to guide patients to-
ward lifestyle modifications they are more likely to adopt.
2  | METHODS
2.1 | Survey design
National Health and Nutrition Examination Survey is a series of 2- year 
national surveys conducted by the Centers for Disease Control and 
Prevention National Center for Health Statistics (NCHS).18 It is de-
signed to monitor the health and nutrition status among children and 
adults in the US. Participants in each survey were randomly selected 
from 30 counties across the country using a complex stratified multi- 
stage clustered sampling design, representative of the US civilian non- 
institutionalized population. The surveys consisted of interviews and 
examinations. Face- to- face interviews were conducted in the partici-
pants’ home to collect information for socio- demographic factors and 
history of diseases. Examinations were performed in mobile exami-
nation centers to obtain measurements of examination and clinical/
laboratory factors. All participants provided informed consent and the 
data were approved by the NCHS Institutional Review Board to ensure 
confidentiality. NCHS strictly complies with the federal laws to safe-
guard against releasing information that could identify a participant 
or a participant’s family to anyone else without participants’ consent 
(https://www.cdc.gov/nchs/data/nhanes-ls/nhanes_confidentiality_
brochure.pdf). The shared data in NHANES are de- identified in the 
sense that all information that could identify the participant and his/
her family has been removed.
2.2 | Study population
In the present study, hypertensive patients with data on non- 
pharmacologic strategies were selected from the NHANES 1999- 
2004. We only included individuals from 1999- 2004 because 
information for non- pharmacologic strategies was not available in the 
other NHANES periods. There were 31 070 individuals interviewed 
or examined in NHANES 1999- 2004; among them, there were 4008 
patients with a diagnosis of hypertension (see the definition below) 
who reported that a doctor had recommended at least one of the 
following non- pharmacologic strategies: weight loss, reduced so-
dium intake, reduced alcohol use, or moderate or vigorous physical 
activity as an adjunct to anti- hypertensive therapy. Those patients 
aged <18 years (n = 8) were excluded since this study focused on 
adults aged ≥18 years with diagnosed hypertension. Thus, a total of 
4000- hypertensive patients, aged ≥18 years were included in the 
study for further analysis.
2.3 | Blood pressure measurements and 
hypertension definition
Blood pressure in NHANES 1999- 2004 was measured by trained phy-
sicians using mercury sphygmomanometry with appropriately sized 
arm cuffs after participants sat and rested for 5 minutes.19 Individuals 
aged ≥18 years without recorded BP were excluded (n = 833). 
Following the American Heart Association recommendations that a 
minimum of 2 BP readings should be taken and the average of those 
readings be used to represent the patient’s BP,20 up to 4 BP readings 
were taken for measurement accuracy in NHANES. We followed the 
NHANES physician examination procedures manual to calculate the 
average BP for each participant.19 In determining mean BP for indi-
viduals, the first BP was used if only 1 measurement was obtained. 
The second BP was used if 2 readings were taken; the mean of the 
last 2 or 3 values were used when 3 or 4 readings were available.7,19,21 
The percentage of individuals with 3 systolic BP readings was 80.7% 
in 1999- 2004. The percentage of individuals with 1 systolic BP was 
7.4% in 1999- 2004. The percentage of individuals with 3 diastolic 
readings was 0.6% lower than for systolic BP and the percentage of 
individuals with 1 measurement was 0.1% higher.
Participants were defined as having hypertension if their mean 
systolic BP was at least 140 mm Hg, mean diastolic BP at least 
90 mm Hg,22 or both, and/or if they were currently taking prescription 
medication to lower BP.7,23
2.4 | Non- pharmacologic strategies
In this study, the strategies investigated as adjuncts to anti- 
hypertensive therapy included weight loss, reduced sodium intake, 
reduced alcohol use, and moderate or vigorous physical activity. They 
were assessed via the questionnaire components in the NHANES 
survey. Participants with a diagnosis of hypertension were first asked 
the following questions: “Have you been told by a doctor to control 
weight for hypertension control?” “Have you been told by a doctor to 
reduce sodium intake for hypertension control?” “Have you been told 
by a doctor to exercise more for hypertension control?” And, “Have 
you been told by a doctor to reduce alcohol consumption for hyper-
tension control?” Hypertensive patients who had been told by a doc-
tor to use one or more of these strategies for BP control were also 
asked “Are you controlling weight or losing weight?” “Are you now 
cutting down on salt or sodium in your diet?” “Are you now exercising 
more?” And, “Are you now cutting down on alcohol consumption?” 
Whether a patient was adopting a specific non- pharmacologic strat-
egy for hypertension control was determined by the response to the 
above questions.
2.5 | Patient characteristics
2.5.1 | Clinical factors
High cholesterol was defined as serum total cholesterol of at least 
199 mg/dL. Serum cholesterol was measured enzymatically in a series 
of coupled reactions that hydrolyze cholesteryl esters and oxidize the 
3- OH group of cholesterol, using a Beckman Synchron LX20. Diabetes 
was diagnosed as a glycohemoglobin (HbA1c) of at least 6.5% or use 
of insulin or diabetes pills to lower blood sugar. HbA1c was measured 
on computerized microprocessors (Model CLC330), which control all 
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functions in a liquid chromatograph and computing integrator. The 
signal from a spectrophotometric detector was processed and the 
concentration of HbA1c was calculated as a percentage of the total 
detected. High triglyceride was defined as the level of triglyceride of 
at least 150 mg/dL.
2.5.2 | Demographic and behavioral factors
Information on age, gender, race/ethnicity, education, and family 
history of hypertension/stroke was self- reported via questionnaire 
components. Age was grouped into 18- 39 years (young adults), 
40- 59 years (middle- aged adults), and 60 years or over (old adults). 
Race/ethnicity included non- Hispanic white, non- Hispanic black, 
Hispanic, and other. Education was classified as high school or below 
and college or above in terms of years in school. Poverty status was 
determined as poor if the family’s poverty income ratio (PIR) was 
less than or equal to 1. PIR was calculated by dividing family total 
income by poverty threshold, which was a guideline specific to family 
size as well as the appropriate year and state, issued each year by the 
Department of Health and Human Services. Body mass index (BMI) 
was calculated as weight in kilograms divided by the squared height in 
meters, and obesity was defined as a BMI of at least 30 kg/m2.
2.6 | Statistical analysis
Analytic and reporting guidelines for NHANES study were followed.24 
Sampling designs and weights were incorporated into data analysis to 
reflect the unequal probability of selection, nonresponse adjustment, 
and adjustment to independent population controls and to increase 
the reliability of parameter estimates, including means, percentages, 
adoption rates, and odds ratios (ORs). Sampling weights were com-
bined for multi- year samples by dividing two- year weights by the 
number of survey cycles. Sampling errors of estimates were calculated 
by using Taylor Series Linearization methods.
Means with 95% confidence intervals (CIs) were calculated for 
continuous data and percentages and/or rates with 95% CIs for cate-
gorical data. Survey F tests were used to compare the means between 
groups and Rao- Scott chi- square tests were conducted for percent-
age or rate comparisons. The difference in means or percentages was 
reported to be significant if the p- value calculated from the t test or 
chi- square test was less than 0.05.
The rate of each non- pharmacologic strategy that was recom-
mended by physicians and used by patients was calculated as the 
weighted number of patients with the positive response (yes) to the 
strategy questions divided by the total weighted number of patients 
who answered the questions (yes or no) in the overall study popula-
tion as well as in the groups defined by each characteristic. Individuals 
with “not sure” or “missing” response were excluded from the rate 
computation. The total number of strategies adopted by patients for 
hypertension control was determined based on the complete data for 
all the 4 investigated strategies. Weighted logistic regression models 
were conducted and ORs with 95% CIs were calculated to identify the 
factors related to the total number of strategies used by patients and 
to the preference of the strategy choice. Wald chi- square test was run 
to evaluate the significance of the factors in influencing the choice of 
strategies. Data analyses were performed on PC using SAS software 
(SAS Institute).
3  | RESULTS
The average age of hypertensive patients in the study was 59.8 years. 
55% were females. 73.8% were non- Hispanic whites, 14.3% were non- 
Hispanic blacks, and 7.9% were Hispanics. Hypertension was uncon-
trolled in 46.8% of patients. Patients who reported having been told 
by physicians to control weight, reduce sodium, exercise more, and/
or reduce alcohol use for hypertension control accounted for 55.6%, 
68.4%, 66.6%, and 25.5%, of the study population, respectively.
Compared to patients with controlled hypertension, patients with 
uncontrolled hypertension were older, less educated, and poorer and 
had lower BMI, higher total cholesterol level, and lower triglyceride 
level (Table 1). Patients with uncontrolled hypertension reported hav-
ing received a physician’s recommendation for non- pharmacological 
strategies less frequently than patients with controlled hypertension 
(weight control: 52.8% vs 58.2%, P = .037; sodium reduction: 66.6% vs 
69.9%, P = .0372; more exercise: 61.0% vs 71.6%, P < .0001; alcohol 
reduction: 22.8% vs 27.9%, P = .0004).
Among hypertensive patients reporting a physician’s recommen-
dation to pursue at least 1 non- pharmacological strategy for hyperten-
sion control, the self- reported adoption rates of the 4 recommended 
strategies- weight control, reduction in sodium intake, more exercise, 
and reduction in alcohol use- were 76.8%, 86.7%, 58.8%, and 76.8%, 
respectively (Table 2). The most frequently reported strategy was so-
dium intake reduction (86.7%), varying according to various patient 
characteristics, from 77.3% in young patients of age 18- 39 years to 
91.8% in non- Hispanic black patients. The least frequently reported 
strategy was “more exercise” (58.8%), and the rates of reporting the 
use of this strategy for hypertension control varied from 54.2% in pa-
tients with diabetes to 65.0% in patients without obesity. The rates at 
which participants reported undertaking weight control and alcohol 
use reduction were similar in the overall population and in each group 
of characteristics; weight control varied from 72.6% in the obese 
group to 84.9% in the non- obese group, and alcohol use reduction 
varied from 73.4% in non- Hispanic whites to 86.8% in Hispanics.
Middle- aged patients were 2.08 fold (OR, 2.08; 95% CI, 1.07- 4.04) 
and old patients were almost 3 fold (OR, 2.99; 95% CI, 1.55- 5.79) 
more likely to report using sodium reduction for hypertension control 
compared to young patients. Female patients were 70% more likely 
than male patients to report undertaking sodium reduction as the 
strategy (Table 3). Compared to non- Hispanic whites, non- Hispanic 
black patients were 36% (OR, 1.36; 95% CI, 1.05- 1.75) more likely to 
undertake weight control, 145% (OR, 2.45; 95% CI, 1.55- 3.89) more 
likely to report using sodium reduction, 44% (OR, 1.44; 95% CI, 1.16- 
1.78) more likely to report undertaking more exercise, and 61% (OR, 
1.61; 95% CI, 1.03- 2.51) more likely to report reducing alcohol use 
as one of the strategies for hypertension control. Hispanic patients 
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Characteristics
Percentages or means (95% confidence intervals)
All
Controlled  
hypertension
Uncontrolled 
hypertension
Count (N) 4000 2130 1870
Age
Mean (y) 59.8 (59.1, 60.5) 59.0 (58.1, 59.9) 60.8 (59.7, 61.8)***
 18- 39 (%) 7.7 (6.2, 9.2) 6.8 (5.5, 8.0) 8.8 (6.2, 11.4)
40- 59 (%) 40.8 (38.6, 43.1) 44.8 (41.4, 48.2) 36.5 (33.3, 39.6)**
≥60 (%) 51.4 (49.3, 53.6) 48.4 (45.2, 51.7) 54.7 (51.8, 57.7)***
Gender
Female (%) 55.0 (52.6, 57.3) 53.1 (50.0, 56.2) 57.0 (53.7, 60.3)
Race/Ethnicity
Non- Hispanic 
white (%)
73.8 (69.7, 77.9) 76.5 (72.6, 80.3) 70.9 (66.2, 75.6)
Non- Hispanic 
black (%)
14.3 (11.0, 17.5) 13.2 (10.3, 16.0) 15.5 (11.6, 19.4)
Hispanic (%) 7.9 (4.9, 10.9) 6.9 (4.0, 9.9) 9.0 (5.7, 12.4)
Education
High school or 
below (%)
54.6 (51.5, 57.7) 52.3 (48.4, 56.2) 57.1 (53.6, 60.6)*
Family poverty income ratio
Mean 2.9 (2.8, 3.0) 3.0 (2.9, 3.1) 2.7 (2.6, 2.9)***
Poor (%) 13.4 (11.6, 15.1) 11.9 (9.9, 13.9) 15.0 (12.4, 17.6)*
Body mass
Mean (kg/m2) 30.9 (30.6, 31.3) 31.4 (30.9, 31.9) 30.5 (30.0, 31.0)***
Obesity (%) 48.3 (46.3, 50.3) 50.4 (47.3, 53.4) 46.0 (42.5, 49.5)
Total cholesterol
Mean (mg/dL) 208.1 (205.9, 210.3) 204.5 (201.2, 207.9) 212.1 (209.6, 214.6)***
High cholesterol 
(%)
56.4 (53.8, 59.1) 52.9 (49.2, 56.6) 60.4 (57.3, 63.5)***
Glycohemoglobin
Mean (%) 5.9 (5.8, 5.9) 5.9 (5.8, 6.0) 5.9 (5.8, 5.9)
Diabetes (%) 15.4 (13.9, 16.9) 16.1 (14.0, 18.2) 14.6 (12.6, 16.7)
Triglyceride
Mean (kg/m2) 172.9 (165.6, 180.3) 177.9 (165.9, 189.9) 166.8 (159.1, 174.5)***
High triglyceride 
(%)
45.9 (42.9, 49.0) 47.0 (42.4, 51.6) 44.6 (40.8, 48.4)
Family history (%) 40.5 (38.1, 42.8) 42.6 (39.5, 45.8) 38.1 (35.1, 41.1)*
Told to control 
weight (%)
55.6 (53.6, 57.7) 58.2 (54.9, 61.5) 52.8 (49.4, 56.1)*
Told to reduce 
sodium (%)
68.4 (66.7, 70.0) 69.9 (67.9, 71.9) 66.6 (64.1, 69.2)*
Told to exercise 
more (%)
66.6 (64.4, 68.7) 71.6 (69.3, 73.8) 61.0 (57.6, 64.4)***
Told to reduce 
alcohol (%)
25.5 (23.5, 27.5) 27.9 (25.3, 30.5) 22.8 (20.6, 25.1)***
*P < .05, **P < .01, ***P < .001 for overall differences in means or percentages of characteristics be-
tween patients with controlled hypertension and patients with uncontrolled hypertension.
TABLE  1 Characteristics of 
hypertensive patients by hypertension 
control status in the study population 
(n = 4000)
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were 87% more likely to report using sodium reduction for BP control. 
Obese patients were 48% (OR, 52%; 95% CI, 0.39- 0.69) less likely to 
report undertaking weight control and 30% (OR, 0.70; 95% CI, 0.52- 
0.94) less likely to report undertaking more exercise than patients 
without obesity. The likelihood of reporting taking more exercise for 
hypertension control decreased by 22% (OR, 0.78; 95% CI, 0.60- 1.01) 
in patients with diabetes compared to non- diabetic patients.
Among hypertensive patients who reported having been told 
by doctors to undertake the 4 non- pharmacologic strategies, 79.1% 
of patients reported using 3 or more non- pharmacological strate-
gies, 12.1% using 2 strategies, and 8.8% using only 1 strategy or not 
using any strategy for hypertension control (Table 4). The percentage 
of patients who reported using 3 strategies or more (range, 73.6%- 
87.4%) was significantly higher than the percentage of patients who 
reported using 2 strategies (range, 6.1%- 15.6%) or the percentage 
who reported using 0 or 1 strategy (range, 2.6%- 14.4%) in the over-
all population (P < .0001), as well as in each group defined by patient 
characteristics (all P values <.0001).
Compared to non- Hispanic whites, non- Hispanic black patients 
were 50% more likely to report using 2 strategies and 82% more likely 
to report using 3 strategies or more for hypertension control; Hispanic 
patients were 83% more likely than white patients to report using 2 
strategies and 124% more likely to report using 3 strategies or more 
(Table 5). Patients with obesity were 64% more likely to report using 
TABLE  2 Self- reported adoption rates and 95% confidence intervals of physician recommended non- pharmacological strategies for 
hypertension control among hypertensive patients (n = 3313)
Characteristics Weight control Reduced sodium intake More exercise
Reduced alcohol 
use
Count (n) 1628 2503 1584 827
All (%) 76.8 (73.2, 80.3) 86.7 (84.4, 89.0) 58.8 (56.5, 61.0) 76.8 (72.2, 81.5)
Age
18- 39 (%) 74.5 (64.1, 84.8) 77.3 (67.6, 87.1) 55.3 (43.1, 67.6) 77.6 (64.9, 90.4)
40- 59 (%) 76.3 (71.4, 81.2) 85.2 (81.1, 89.3) 57.9 (53.9, 61.9) 77.9 (70.8, 85.0)
≥60 (%) 77.7 (73.7, 81.7) 89.5 (87.2, 91.8) 60.2 (57.4, 63.0) 75.4 (70.4, 80.4)
Gender
Female (%) 75.6 (71.7, 79.4) 90.2 (88.2, 92.1) 57.1 (54.0, 60.1) 79.7 (74.2, 85.3)
Male (%) 78.1 (73.4, 82.9) 82.6 (79.0, 86.2) 60.8 (56.8, 64.9) 74.8 (68.5, 81.1)
Race/Ethnicity
Non- Hispanic white (%) 75.6 (71.3, 79.9) 84.9 (81.9, 88.0) 56.8 (54.0, 59.6) 73.4 (68.0, 78.8)
Non- Hispanic black (%) 78.9 (76.0, 81.9) 91.8 (89.4, 94.1) 62.6 (58.7, 66.5) 81.8 (76.3, 87.3)
Hispanic (%) 78.5 (68.1, 88.9) 89.6 (85.7, 93.5) 63.0 (54.1, 71.8) 86.8 (78.0, 95.6)
Education
High school or below (%) 76.0 (71.9, 80.0) 86.4 (83.6, 89.3) 58.2 (54.6, 61.9) 76.3 (70.1, 82.4)
College or above (%) 77.6 (73.3, 82.0) 87.0 (83.7, 90.4) 59.3 (56.0, 62.6) 77.6 (71.7, 83.4)
Family poverty income ratio
Poor (%) 76.8 (68.7, 84.9) 85.9 (81.2, 90.7) 55.7 (49.2, 62.2) 81.9 (72.1, 91.6)
Non- poor (%) 76.8 (72.6, 80.9) 86.2 (83.8, 88.6) 60.0 (57.0, 63.0) 75.6 (70.5, 80.8)
Body mass index
Obesity (%) 72.6 (68.3, 77.0) 85.8 (83.3, 88.4) 54.5 (51.2, 57.8) 77.2 (70.8, 83.6)
Non- obesity (%) 84.9 (81.6, 88.3) 87.2 (83.4, 91.0) 65.0 (60.4, 69.5) 76.0 (69.5, 82.6)
Total cholesterol
High cholesterol (%) 76.1 (70.9, 81.3) 85.8 (82.6, 88.9) 57.4 (53.6, 61.2) 74.9 (69.0, 80.7)
Normal (%) 78.5 (74.8, 82.2) 87.4 (84.4, 90.3) 61.0 (57.1, 64.9) 79.7 (74.3, 85.2)
Glycohemoglobin
Diabetes (%) 75.2 (69.9, 80.5) 89.6 (85.4, 93.8) 54.2 (49.3, 59.1) 79.4 (72.0, 86.7)
Non- diabetes (%) 77.4 (73.6, 81.2) 85.9 (83.5, 88.4) 60.1 (57.5, 62.7) 76.5 (71.2, 81.8)
Triglyceride
High triglyceride (%) 76.9 (72.1, 81.8) 87.0 (82.6, 91.4) 54.4 (49.6, 59.1) 75.8 (67.5, 84.2)
Normal (%) 78.1 (71.8, 84.3) 86.9 (82.4, 91.5) 62.6 (57.9, 67.3) 77.7 (69.5, 85.9)
Family history (%) 76.1 (70.8, 81.4) 86.9 (83.6, 90.2) 57.5 (52.6, 62.4) 77.5 (70.7, 84.3)
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2 strategies, and were 68% more likely to report using 3 strategies for 
BP control than non- obese patients. The likelihoods of reporting the 
use of 2 strategies and 3 strategies or more increased 66% and 62%, in 
diabetic patients relative to non- diabetic patients, respectively.
4  | DISCUSSION
We investigated 4 non- pharmacological strategies for BP control—
weight control, reduction in sodium intake, more exercise, and reduc-
tion in alcohol use, as self- reported by NHANES participants. These 
strategies can serve as initial treatment before the start of drug 
therapy and as an adjunct to medication in persons already on drug 
therapy. In hypertensive individuals with medication- controlled BP, 
these strategies can facilitate drug step- down and drug withdrawal 
in highly motivated individuals who achieve and sustain lifestyle 
changes.25 Although accumulating evidence reveals that these strat-
egies have significant effects on reducing BP,11,13,26,27 our analysis 
shows that relatively few people report that these strategies have 
been recommended by physicians for hypertension control. Among 
hypertensive patients, 55.6% were told to control weight, 68.4% were 
told to reduce sodium intake, and 66.6% were told to exercise more 
and reduce alcohol use. The chance of reporting undertaking lifestyle 
modifications beyond medications for hypertension control is higher 
in patients who report receiving physician’s advice than patients not 
reporting any advice.28 To the extent that a self- report is accurate, 
less frequent recommendations for lifestyle interventions represent a 
lost opportunity for BP reduction and control. Investigation of physi-
cian characteristics as predictors for prescribing non- pharmacological 
strategies is needed in order to improve hypertension control among 
hypertensive patients.
Among hypertensive patients who report having been told by 
physicians to take non- pharmacological strategies, more exercise was 
the least frequent self- reported strategy (58.8%) used for hyperten-
sion control. Regular aerobic physical activity can facilitate weight 
loss, decrease BP, and reduce the overall risk of cardiovascular dis-
ease.22,29 BP may be lowered by 4- 9 mm Hg with moderately intense 
physical activity including brisk walking for 30 minutes a day, 5 days 
per week.22 Non- preference for undertaking more exercise for BP 
control necessitates new strategies to engage hypertensive patients 
in more physical activity to reduce BP and improve cardiovascular 
health outcomes. Among hypertensive patients who reported receiv-
ing advice, the proportion that reported choosing to take at least 2 
non- pharmacological strategies was much higher than the proportion 
that reported using a single strategy (91.2% vs 8.8%). As judged by 
the self- reports, physician advice appears to be an effective motivator 
for undertaking hypertension- related non- pharmacological strategies 
in individuals with hypertension regardless of gender, race/ethnicity, 
or other characteristics.
Obese patients were more likely to report using at least 2 non- 
pharmacological strategies for hypertension control. Obesity is a 
major risk factor for hypertension treatment and control.7,30 Weight 
reduction may lower BP by 5- 20 mm Hg per 10 kg of weight loss in an 
overweight or obese individual.22 The DASH eating plan encompasses 
TABLE  3  Impact of socio- demographic and clinical factors on self- reported choice of physician recommended non- pharmacologic strategies 
among hypertensive patients (n = 3313)
Characteristics
Weight control (n = 2085)
Reduced sodium intake 
(n = 2805) More exercise (n = 2579)
Reduced alcohol use 
(n = 1022)
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Age (vs 18- 39 y)
40- 59 y 1.36 0.78- 2.38 2.08* 1.07- 4.04 1.26 0.69- 2.30 1.31 0.58- 2.98
≥60 y 1.28 0.70- 2.33 2.99** 1.55- 5.79 1.34 0.73- 2.46 1.33 0.57- 3.14
Gender (vs male)
Female 0.91 0.69- 1.19 1.70*** 1.26- 2.29 0.85 0.67- 1.09 1.30 0.88- 1.91
Race/Ethnicity (vs non- Hispanic white)
Non- Hispanic black 1.36* 1.05- 1.75 2.45*** 1.55- 3.89 1.44*** 1.16- 1.78 1.61* 1.03- 2.51
Hispanic 1.30 0.70- 2.43 1.87* 1.01- 3.46 1.40 0.89- 2.22 2.02 0.82- 4.98
Education (vs college or above)
High school or below 0.97 0.72- 1.31 0.78 0.54- 1.15 0.92 0.68- 1.24 0.82 0.48- 1.38
Poverty status (vs non- poor)
Poor 0.99 0.59- 1.67 0.80 0.50- 1.28 0.84 0.59- 1.20 1.28 0.68- 2.42
Obesity 0.52*** 0.39- 0.69 0.97 0.64- 1.45 0.70* 0.52- 0.94 1.06 0.68- 1.67
High cholesterol 0.85 0.64- 1.15 0.83 0.59- 1.17 0.89 0.69- 1.16 0.79 0.54- 1.15
Diabetes 0.87 0.64- 1.18 1.32 0.84- 2.08 0.78* 0.60- 1.01 1.11 0.63- 1.94
Family history 0.87 0.58- 1.31 1.06 0.74- 1.52 0.98 0.75- 1.29 1.08 0.62- 1.89
CI, confidence interval; OR, odds ratio.
*P < .05, **P < .01, ***P < .001 for the impact of factors on the choice of non- pharmacological strategies among hypertensive patients.
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a diet rich in fruits, vegetables, and low- fat dairy products and may 
lower body weight and thus lower BP by 8- 14 mm Hg.31 Hypertension 
programs and studies might inform hypertensive patients with obe-
sity to be more aware of their increased risks of uncontrolled BP and 
adverse cardiovascular outcomes, and to be more willing to under-
take multiple strategies rather than a single strategy for BP control. 
However, our data also shows that obese patients were less likely to 
report undertaking weight control or more exercise as a strategy be-
yond medications. This indicates that obesity is not only a risk factor 
for resistance to hypertension treatment, but also a risk factor for non- 
adherence to physical activity recommended by physicians. The rea-
son obese people report less preference for increasing their exercise 
for hypertension control remains unclear. One possible reason is that 
obesity is associated with many adverse health outcomes (eg, diabetes 
and heart disease with joint discomfort), and these outcomes might 
limit exercise tolerance in patients and hence predispose them to 
avoid physical activity as a BP control strategy.32 This explanation is 
also supported by the finding in this study that patients with diabetes 
were less likely to report undertaking weight control and more exer-
cise for hypertension control.
Our analysis shows that Non- Hispanic blacks and Hispanics were 
more likely than non- Hispanic whites to report undertaking multi-
ple non- pharmacological strategies (≥2) for BP control. Compared to 
non- Hispanic whites, non- Hispanic blacks have higher prevalence and 
TABLE  4 Percentages (95% confidence intervals) of the total number of physician recommended non- pharmacological strategies adopted 
by hypertensive patients (n = 3313)
Characteristics
Total numbers of strategies used
0 or 1 2 3 or more
Count (%) 239 (7.2%) 408 (12.3%) 2666 (80.5%)
Age
18- 39 (%) 14.4 (0.0, 30.4) 12.0 (1.1, 22.9) 73.6 (55.2, 92.0)*
40- 59 (%) 8.4 (3.1, 13.6) 13.3 (8.7, 17.9) 78.3 (72.5, 84.1)*
≥60 (%) 7.8 (4.4, 11.1) 10.7 (5.8, 15.6) 81.6 (76.1, 87.0)*
Gender
Female (%) 6.6 (2.8, 10.4) 12.7 (7.4, 17.9) 80.7 (74.8, 86.7)*
Male (%) 10.5 (4.2, 16.9) 11.6 (6.7, 16.5) 77.8 (72.5, 83.2)*
Race/Ethnicity
Non- Hispanic white (%) 9.6 (4.7, 14.6) 13.2 (7.5, 19.0) 77.1 (72.1, 82.1)*
Non- Hispanic black (%) 8.8 (4.7, 13.0) 10.8 (5.5, 16.0) 80.4 (76.1, 84.7)*
Hispanic (%) 2.6 (0.0, 5.7) 12.0 (3.8, 20.1) 85.4 (76.2, 94.7)*
Education
High school or below (%) 10.5 (5.8, 15.2) 15.1 (9.9, 20.3) 74.4 (69.9, 79.0)*
College or above (%) 6.7 (1.5, 11.9) 8.1 (4.5, 11.7) 85.2 (79.2, 91.3)*
Family poverty income ratio
Poor (%) 7.4 (1.0, 13.7) 13.1 (4.5, 21.8) 79.5 (68.7, 90.3)*
Non- poor (%) 9.7 (5.1, 14.3) 12.1 (7.2, 17.1) 78.2 (74.0, 82.4)*
Body mass index
Obesity (%) 10.6 (5.4, 15.9) 15.6 (10.2, 20.9) 73.8 (68.4, 79.2)*
Non- obesity (%) 6.6 (3.0, 10.1) 6.1 (1.7, 10.5) 87.4 (82.6, 92.1)*
Total cholesterol
High cholesterol (%) 7.6 (4.7, 10.5) 13.6 (8.1, 19.2) 78.8 (72.9, 84.6)*
Normal (%) 10.4 (3.6, 17.3) 10.3 (5.7, 14.8) 79.3 (73.0, 85.6)*
Glycohemoglobin
Diabetes (%) 5.6 (1.7, 9.5) 15.0 (7.8, 22.3) 79.4 (71.6, 87.2)*
Non- diabetes (%) 9.6 (5.1, 14.0) 11.5 (6.5, 16.6) 78.9 (74.9, 82.9)*
Triglyceride
High triglyceride (%) 9.3 (1.9, 16.6) 12.8 (7.7, 18.0) 77.9 (69.7, 86.1)*
Normal (%) 6.6 (1.8, 11.4) 10.4 (2.8, 18.1) 83.0 (73.9, 92.1)*
Family history (%) 9.2 (2.5, 15.8) 12.4 (7.0, 17.9) 78.4 (70.9, 85.9)*
*P < .001 for the differences in rates between groups determined by the number of non- pharmacological strategies adopted by hypertensive patients.
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awareness of hypertension and lower hypertension control and are 
more likely to be under treatment.7,33,34 More awareness of the risk 
of uncontrolled BP among non- Hispanic blacks may be a motivator 
to take more lifestyle modification techniques beyond medications, 
following the clinical recommendations by physicians35 to improve 
BP control. Hispanics with hypertension have lower treatment and 
lower control rates than non- Hispanic whites.7,34 One possible rea-
son for Hispanics to report using multiple strategies is that Hispanic 
patients were more likely to report receiving physician’s advice for 
non- pharmacological strategies than non- Hispanic whites (39% more 
for weight control, 32% more for sodium intake reduction, 57% more 
for more exercise, and 100% more for alcohol use reduction in this 
study). Another possible reason is that knowledge of increased risk of 
uncontrolled hypertension among Hispanic patients may also motivate 
them to take more strategies than non- Hispanic whites to control BP 
as non- Hispanic black patients did in this study.
Uncontrolled hypertension is significantly associated with age 
and older people have higher rates of uncontrolled hypertension 
compared to younger people. Although older patients should take 
strategies beyond anti- hypertensive treatment for hypertension 
control, our study indicates that middle- aged and old patients did 
not report using non- pharmacological strategies (except for sodium 
intake reduction), and/or use at least 2 strategies more frequently 
than young patients to control hypertension. This cannot be simply 
explained by the limited physical capacity in older patients. More 
attention should be paid on how to engage older people in using 
more available lifestyle modifications for BP control. Older patients 
were more likely to report undertaking sodium reduction in our 
study. This presents evidence that diet- related programs, such as 
the DASH diet31 and the Mediterranean diet36 might be more ap-
propriate and more likely to be successful for older patients. These 
programs can help older people with hypertension improve BP con-
trol through eating healthy and losing weight.31,37 In the meantime, 
exercise related programs that are well suited for older people need 
to be more widely available.
The NHANES program includes a large survey sample with a 
stratified multi- stage sampling design, ensuring adequate power to 
obtain unbiased estimates. There are several limitations in this study. 
It is possible that self- reporting does not accurately reflect physi-
cians’ advice or patients’ use of blood pressure reduction strategies 
(even the use of medications). For example, self- reported sodium 
intake has been found to correlate poorly with urinary sodium ex-
cretion.38 The issue of accuracy of a self- report is inherent to studies 
that ask for patients’ perspectives. Irrespective of the accuracy of a 
self- report, the findings of our study provide valuable insight into 
the issue of physicians’ advice and adoption of that advice—directly 
from the patient’s perspective. BP measurements were obtained at 
a single time point may capture some patients without persistent 
hypertension. In clinical practice, it is preferable to rely upon blood 
pressure estimates separated in time. However, the reliability of 
the blood pressure estimate provided by the NHANES’ protocol is 
greater than that obtained in routine clinical practice, since the aver-
age of up to 4 separate measurements was obtained under the same 
standardized conditions in each of the surveys. Race/ethnicity of the 
health care provider may impact the patient- provider relationship,39 
which might have a significant impact on the recommendation of 
Characteristics
2 (vs 0 or 1) 3 or more (vs 0 or 1)
OR 95% CI OR 95% CI
Age (vs 18- 39 y)
40- 59 y 1.46 0.90- 2.39 1.27 0.73- 2.20
≥60 y 1.36 0.85- 2.19 0.99 0.61- 1.60
Gender (vs male)
Female 0.87 0.65- 1.16 0.81 0.64- 1.02
Race/Ethnicity (vs non- Hispanic white)
Non- Hispanic black 1.50* 1.05- 2.13 1.82*** 1.44- 2.29
Hispanic 1.83* 1.16- 2.89 2.24*** 1.41- 3.57
Education (vs college or above)
High school or below (%) 1.07 0.81- 1.42 1.00 0.77- 1.30
Poverty status (vs non- poor)
Poor 0.93 0.66- 1.32 0.89 0.60- 1.31
Obesity 1.64*** 1.24- 2.15 1.68*** 1.40- 2.03
High cholesterol 0.80* 0.67- 0.96 0.77* 0.62- 0.97
Diabetes 1.66* 1.12- 2.44 1.62** 1.15- 2.27
Family history 1.20 0.89- 1.63 1.20 0.91- 1.58
CI, confidence interval; OR, odds ratio.
*P < .05, **P < .01, ***P < .001 for the impact of factors on the number of non- pharmacological strate-
gies adopted by hypertensive patients.
TABLE  5  Impact of socio- demographic 
and clinical factors on the number of 
physician recommended non- 
pharmacological strategies adopted by 
hypertensive patients (n = 3313)
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and adherence to the non- pharmacological strategies described in 
our study; however, health care provider racial/ethnic information 
was not captured in NHANES to evaluate such impact. Our defini-
tion of hypertension excluded hypertensive individuals with BP suc-
cessfully controlled by physical activity, weight control, and other 
non- pharmacological techniques. Participants who have been diag-
nosed to have hypertension but are not receiving medications are 
not counted as hypertensive.
In conclusion, among hypertensive patients who reported having 
been told by physicians to undertake non- pharmacological strategies, 
a great majority of patients reported adopting multiple strategies (≥2) 
for hypertension control. Physicians’ clinical advice, as recalled by pa-
tients, appears to play an important role in the number of strategies pa-
tients report adopting. Sodium intake reduction was the most reported 
adopted strategy and “more exercise” was the least adopted strategy 
by self- reports. Non- Hispanic blacks and Hispanics were more likely to 
report using at least 2 strategies, and non- Hispanic blacks were also 
more likely to report taking each single strategy, whereas Hispanics 
were more likely to report choosing sodium reduction for BP control. 
Hypertensive patients with obesity and diabetes were less likely to re-
port undertaking more exercise compared to the corresponding peers. 
Education programs should be developed to enhance physicians’ abil-
ity to dispense effective advice for lifestyle modifications and to in-
crease patients’ engagement in physical activity.
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